2017-03-23,Dicerna To Report Fourth Quarter And Full Year 2016 Financial Results And Host Conference Call On March 30, 2017
2017-03-01,Dicerna To Present At Cowen And Company 37th Annual Health Care Conference
2017-02-08,Dicerna To Participate In Fireside Chat At The Leerink Partners Global Healthcare Conference
2017-02-02,Dicerna Pharmaceuticals, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2016-11-09,Dicerna To Present At The Stifel 2016 Healthcare Conference
2016-11-07,Dicerna Reports Third Quarter 2016 Financial And Operational Results
2016-10-31,Dicerna To Report Third Quarter 2016 Financial Results And Host Conference Call On November 7, 2016
2016-09-26,Dicerna Prioritizes Resources To Advance GalXC™ Product Candidates
2016-09-06,Dicerna To Present At September Investor Conferences
2016-08-04,Dicerna Reports Second Quarter 2016 Financial And Operational Results
2016-07-28,Dicerna To Report Second Quarter 2016 Financial Results And Host Conference Call On August 4, 2016
2016-06-29,New Preclinical Data Show Potential Of Dicerna GalXC™ Subcutaneous Delivery Platform As RNAi Drug Discovery Engine
2016-06-29,7 Stocks Under $10 Making Big Moves
2016-06-15,Dicerna Appoints Martin Freed, M.D., To Board Of Directors
2016-06-02,Dicerna To Present At The Jefferies 2016 Healthcare Conference
2016-05-13,Dicerna Announces Dosing Of First Patient In Phase 1 Clinical Trial Of DCR-PH1 In Patients With Primary Hyperoxaluria Type 1 (PH1)
2016-05-11,Dicerna Reports Potent Preclinical Activity With GalNAc-DsiRNA-EX Conjugates
2016-05-09,Dicerna Reports First Quarter 2016 Financial And Operational Results
2016-05-02,Dicerna To Report First Quarter 2016 Financial Results And Host Conference Call On May 9, 2016
2016-04-18,John B. "Jack" Green, Chief Financial Officer At Dicerna (Photo: Business Wire)
2016-03-20,8 Biotech Stocks Under $10 Making Big Moves Higher
2016-03-10,Dicerna Announces Fourth Quarter And Full Year 2015 Financial And Operational Results
2016-03-04,Dicerna To Announce Fourth Quarter And Full Year 2015 Financial Results And Host Conference Call On March 10, 2016
2016-03-03,5 Stocks Under $10 Set to Soar
2016-03-02,Dicerna To Present At Two March Conferences
2016-02-25,Dicerna Reports Progress With GalNAc-DsiRNA-EX-Conjugates
2016-02-04,Dicerna To Present At The 2016 Leerink Partners Global Healthcare Conference
2016-01-11,Dicerna Pharmaceuticals Becomes Oversold (DRNA)
2015-12-31,Dicerna Pharmaceuticals, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2015-12-21,Dicerna Begins Dosing In First Clinical Trial Of Therapy For Primary Hyperoxaluria Type 1 (PH1) In Healthy Volunteers
2015-12-21,Dicerna Updates Progress on the Development of DCR-MYC for the Treatment of Solid Tumors
2015-12-16,Dicerna Announces Addition To NASDAQ Biotechnology Index
2015-12-15,Dicerna Pharmaceuticals Appoints John "Jack" Green Interim Chief Financial Officer
2015-11-13,Dicerna To Present At Two November Conferences
2015-11-10,Dicerna Announces Third Quarter 2015 Financial And Operational Results
2015-11-03,Dicerna To Announce Third Quarter 2015 Financial Results And Host Conference Call On November 10, 2015
2015-09-30,Dicerna Pharmaceuticals, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2015-09-30,Dicerna To Present Advances In Conjugate Delivery Technology At Leerink Partners Rare Disease Roundtable
2015-09-24,Dicerna To Present At The Leerink Partners Rare Disease Roundtable
2015-09-18,5 Stocks Ready for Breakouts
2015-08-06,Dicerna Announces Second Quarter 2015 Financial And Operational Results
2015-08-06,EMA Grants Orphan Drug Designation To DCR-PH1, Dicerna's Investigational Therapy For The Treatment Of Primary Hyperoxaluria Type 1 (PH1)
2015-07-29,Dicerna To Announce Second Quarter 2015 Financial Results And Host Conference Call On August 6, 2015
2015-07-01,Dicerna Pharmaceuticals, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2015-06-19,Dicerna To Present At The JMP Securities Life Sciences Conference 2015
2015-06-11,Dicerna Responds To Alnylam Complaint
2015-06-05,Dicerna Pharmaceuticals Enters Oversold Territory (DRNA)
2015-06-01,Dicerna Presents Preliminary Safety And Efficacy Data From DCR-MYC Phase 1 Study In Patients With Advanced Solid Tumors At The 2015 ASCO Annual Meeting
2015-05-29,Dicerna To Present At The Jefferies 2015 Healthcare Conference
2015-05-20,Dicerna Announces Pricing Of Follow-On Offering Of Common Stock
2015-05-18,Dicerna Announces Follow-On Public Offering Of Common Stock
2015-05-14,Dicerna Announces Expansion Of Ongoing DCR-MYC Phase 1 Study To Evaluate Safety And Efficacy In Patients With Advanced Pancreatic Neuroendocrine Tumors (PNETs)
2015-05-13,Dicerna To Present Interim Clinical Data From First DCR-MYC Phase 1 Study In Patients With Advanced Solid Tumors At The 2015 ASCO Annual Meeting
2015-05-11,Dicerna Announces First Quarter 2015 Financial And Operational Results
2015-05-06,Dicerna Announces Potent, Durable Knockdown Of Gene Expression In Non-human Primates With DsiRNA-EX Conjugates Being Investigated For Treatment Of Primary Hyperoxaluria Type 1 (PH1)
2015-05-04,Dicerna To Present At The 17th Annual TIDES: Oligonucleotide And Peptide® Therapeutics From Research Through Commercialization Conference
2015-04-29,Dicerna To Present At The Deutsche Bank 40th Annual Health Care Conference
2015-04-29,Dicerna To Announce First Quarter 2015 Financial Results And Host Conference Call On May 11, 2015
2015-04-23,FDA Grants Orphan Drug Designation For DCR-PH1, Dicerna's Investigational Therapy For The Treatment Of Primary Hyperoxaluria Type 1 (PH1)
2015-04-10,Dicerna Presents New ß-catenin Data From Multiple Tumor Models At The 2015 RNA & Oligonucleotide Therapeutics Meeting At Cold Spring Harbor Laboratory
2015-04-06,Relative Strength Alert For Dicerna Pharmaceuticals
2015-03-31,Dicerna Pharmaceuticals, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2015-03-19,'Mad Money' Lightning Round: I'm Staying Away From Five Below
2015-03-18,Jim Cramer's 'Mad Money' Recap: The Fed Does the Right Thing
2015-03-12,Dicerna Announces Fourth Quarter And Full Year 2014 Financial And Operational Results
2015-03-10,5 Hated Earnings Stocks You Should Love
2015-03-09,Dicerna To Announce Fourth Quarter And Full Year 2014 Financial Results And Host Conference Call On March 12, 2015
2015-02-26,Dicerna Pharmaceuticals Announces Move To Larger Office And Lab Space In Cambridge, Massachusetts
2015-02-04,Dicerna To Present At The 2015 Leerink Global Healthcare Conference
2015-02-02,Dicerna Pharmaceuticals Announces First Patient Dosed In Phase 1b/2 Clinical Trial Of DCR-MYC, An Investigational RNAi Therapeutic Targeting The MYC Oncogene, In Patients With Advanced Hepatocellular Carcinoma
2015-01-12,Dicerna Announces Issuance Of US Patent Providing Broad Coverage Of DsiRNA-EX RNAi Payloads
2015-01-12,Dicerna Pharmaceuticals Presents Positive Preclinical Data On Its DsiRNA Therapeutics Targeting MYC And ß-Catenin At AACR MYC: From Biology To Therapy Meeting
2014-12-17,Dicerna Announces The Appointment Of Theodore T. Ashburn, M.D., Ph.D. To Senior Vice President, Product Strategy And Operations, And Inducement Grant Of Stock Options Under NASDAQ Listing Rule 5635 (c)(4)
2014-12-15,Dicerna R&D Update Webcast Reminder
2014-11-25,Dicerna To Present At The 2014 Deutsche Bank BioFEST
2014-11-17,Dicerna Reports On Progress Of Development Programs
2014-11-17,Dicerna Announces License Agreement With Tekmira To Advance Dicerna's PH1 Development Program
2014-11-14,Dicerna To Present At Two Upcoming Investor Conferences
2014-11-06,Dicerna Announces Third Quarter 2014 Financial And Operational Results
2014-11-04,Oversold Conditions For Dicerna Pharmaceuticals (DRNA)
2014-10-24,Dicerna To Announce Third-Quarter 2014 Financial Results And Host Conference Call On November 6, 2014
2014-10-14,Dicerna Presents Preclinical Data For Investigational RNAi Therapeutic DCR-PH1 In Primary Hyperoxaluria Type 1 (PH1) At The 10th Annual Meeting Of The Oligonucleotide Therapeutics Society
2014-10-14,Oversold Conditions For Dicerna Pharmaceuticals (DRNA)
2014-09-29,Dicerna To Present At Three Upcoming Investor Conferences
2014-09-15,Dicerna Announces Appointment Of Biotech Industry Leader Bruce Peacock To Its Board Of Directors And Audit Committee
2014-09-02,Dicerna To Present At The Baird 2014 Health Care Conference
2014-08-21,Dicerna Announces The Issuance Of Multiple Patents Covering Claims For Dicer Substrate SiRNAs
2014-08-19,Dicerna Pharmaceuticals Becomes Oversold (DRNA)
2014-08-07,Dicerna Provides Operational Update And Reports Second Quarter 2014 Financial Results
2014-07-28,3 Stocks Spiking on Big Volume
2014-07-25,Dicerna To Announce Second-Quarter 2014 Financial Results And Host Conference Call On August 7, 2014
2014-07-11,Dicerna To Ring The NASDAQ Stock Market Closing Bell July 15th
2014-07-01,3 Stocks Spiking on Big Volume
2014-02-06,Top Insider Trades: DRNA RGLS RARE CARA
,
,
